Sr. Director, Procurement, Clinical Development, Category Group Head at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Visionary and strategic procurement leadership experience
  • Expertise in transforming categories such as Lab, Diagnostics, Digital, Data, and Patient & Site Solutions (Clinical Enablement)
  • Ability to integrate supplier innovation, digital technology, and data-driven execution
  • Experience defining and executing category strategies aligned with R&D, Global Procurement, and corporate priorities
  • Proven track record in enterprise-level direction across multiple categories and therapeutic areas
  • Skills in driving cross-enterprise alignment through forums like Innovation Councils, Category SteerCos, and executive governance
  • Leadership in procurement modernization, including innovative pricing models, supplier relationship management (SRM), transparency, and performance metrics
  • Proficiency in embedding advanced analytics, AI-enabled tools, and SRM frameworks
  • Experience as a trusted strategic partner to senior R&D and enterprise leaders, influencing investments and partnerships
  • Ability to collaborate across Development, Finance, Legal, and Digital functions
  • Global team leadership, mentoring, performance management, and succession planning experience
  • Capability to foster a culture of accountability, inclusion, and continuous improvement

Responsibilities

  • Provide enterprise-level direction across multiple categories and therapeutic areas, aligning with R&D, Global Procurement, and BMS corporate priorities
  • Define and execute transformative category strategies integrating technology, digital capabilities, and innovative supplier solutions to accelerate clinical development
  • Drive cross-enterprise alignment and collaboration via Innovation Councils, Category SteerCos, and executive governance forums
  • Lead modernization initiatives in innovative pricing models, enhanced supplier relationship management, transparency, and performance
  • Evolve procurement operations from transactional to strategic using advanced analytics, AI-enabled decision tools, and SRM frameworks
  • Serve as a trusted strategic partner to senior R&D and enterprise leaders, influencing investment decisions and supplier partnerships impacting drug development
  • Collaborate across Development, Finance, Legal, and Digital functions for cohesive execution of priorities and integration between R&D and Global Procurement
  • Lead, mentor, and inspire a global team of procurement professionals and senior managers, ensuring clarity, performance management, and succession planning
  • Foster a culture of accountability, inclusion, and continuous improvement to build next-generation procurement leadership
  • Deliver measurable operational, financial, and innovation-driven outcomes through advanced category management

Skills

Procurement
Category Management
Strategic Sourcing
Supplier Innovation
Digital Technology
Data Analytics
Automation
Performance Contracting
Stakeholder Alignment
Supplier Collaboration

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI